Paper Details

  1. Home
  2. Paper Details

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.

Author: KantoffPhilip W, LifseyDeborah, NakabayashiMari, OhWilliam K, ReganMeredith M, SartorOliver, TaplinMary-Ellen

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.

Overview

Nilutamide is being evaluated as a secondary hormonal therapy for patients with androgen-independent prostate cancer. This therapy is attractive because it is orally administered, has low toxicity, and is well-accepted by patients.
Paper Details　
Original Abstract of the Article :
To evaluate the activity of nilutamide as secondary hormonal therapy in patients with androgen-independent prostate cancer (AIPC), as treatment options are limited for these patients and secondary hormonal therapy with antiandrogens has advantages, including low toxicity, oral administration and hig...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1464-410X.2005.05714.x

データ提供：米国国立医学図書館（NLM）

Nilutamide: A New Oasis in the Fight Against Prostate Cancer

Androgen-independent prostate cancer (AIPC) represents a challenging stage of the disease, often requiring innovative treatment approaches. This research investigates the efficacy of nilutamide, an antiandrogen, as secondary hormonal therapy for patients with AIPC. The study aimed to evaluate the effectiveness of nilutamide in treating AIPC, exploring its advantages in terms of low toxicity, oral administration, and patient acceptance.

Imagine a caravan searching for an oasis in a vast and unforgiving desert. This research, like a guide leading the way, explores the potential benefits of nilutamide in battling AIPC, a challenging foe in the fight against prostate cancer.

A New Weapon in the Arsenal Against AIPC

This research provides evidence that nilutamide can be an effective treatment option for patients with AIPC. Its advantages of low toxicity, oral administration, and high patient acceptance make it a valuable tool in managing this challenging form of prostate cancer.

Navigating the Treatment Landscape of AIPC

This research emphasizes the importance of exploring new treatment options for AIPC, a critical area in prostate cancer management. It highlights the potential of nilutamide to provide a safer and more tolerable alternative to existing therapies.

Dr.Camel's Conclusion

This research, like a camel navigating a treacherous desert, offers a glimmer of hope in the fight against AIPC. Nilutamide, like a refreshing oasis, provides a new avenue for treating this challenging form of prostate cancer.

Date :
  1. Date Completed 2005-10-20
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

16153200

DOI: Digital Object Identifier

10.1111/j.1464-410X.2005.05714.x

Related Literature

Article Analysis
・Side Effects of nilutamide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.